Click-Chemistry Based High Throughput Screening Platform for Modulators of Ras Palmitoylation

• DOI: 10.1038/srep41147
• Publication Date: 2017-01-23T11:40:40Z
• Authors: Lakshmi Ganesan; Peyton Shieh; Carolyn R. Bertozzi; Ilya Levental
• Keywords: 0303 health sciences; 03 medical and health sciences; Lipoylation; Drug Evaluation, Preclinical; ras Proteins; Click Chemistry; Proto-Oncogene Proteins c-fyn; Article; High-Throughput Screening Assays; 3. Good health

AbstractPalmitoylation is a widespread, reversible lipid modification that has been implicated in regulating a variety of cellular processes. Approximately one thousand proteins are annotated as being palmitoylated, and for some of these, including several oncogenes of the Ras and Src families, palmitoylation is indispensable for protein function. Despite this wealth of disease-relevant targets, there are currently few effective pharmacological tools to interfere with protein palmitoylation. One reason for this lack of development is the dearth of assays to efficiently screen for small molecular inhibitors of palmitoylation. To address this shortcoming, we have developed a robust, high-throughput compatible, click chemistry-based approach to identify small molecules that interfere with the palmitoylation of Ras, a high value therapeutic target that is mutated in up to a third of human cancers. This assay design shows excellent performance in 384-well format and is sensitive to known, non-specific palmitoylation inhibitors. Further, we demonstrate an ideal counter-screening strategy, which relies on a target peptide from an unrelated protein, the Src-family kinase Fyn. The screening approach described here provides an integrated platform to identify specific modulators of palmitoylated proteins, demonstrated here for Ras and Fyn, but potentially applicable to pharmaceutical targets involved in a variety of human diseases.